Nuo Therapeutics Inc (AURX) earnings · rev $3.1M
Nuo Therapeutics Inc (AURX) is a biotechnology company listed on US.
This AURX earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported AURX revenue for 2026-06-30 was $3.1M. Net income was -$896.1K. AURX currently screens at market cap $72.1M.
When the next AURX 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
Period-over-period revenue change is not in cache for AURX. We will not invent a beat or miss.
Not investment advice. Full AURX research stays on the stock page; the tape stays on the quote page.
Not investment advice.